Page 136 - 南京医科大学自然版

第46卷第6期
·918 · 南 京 医 科 大 学 学 报 2026年6月

PEG⁃PLA copolymer and determination of factors control⁃ ［39］BUKHARI M M，ALKHAMEES B F，HUSSAIN S，et al.
ling the particle size using artificial neural network［J］. J An improved artificial neural network model for effective
Microencapsul，2011，28（5）：406-416 diabetes prediction［J］. Complexity，2021，2021（1）：
［28］ LI Y Q，ABBASPOUR M R，GROOTENDORST P V，et 5525271
al. Optimization of controlled release nanoparticle formu⁃ ［40］ HIRSCHBERG C，EDINGER M，HOLMFRED E，et al.
lation of verapamil hydrochloride using artificial neural Image ⁃ based artificial intelligence methods for product
networks with genetic algorithm and response surface control of tablet coating quality［J］. Pharmaceutics，2020，
methodology［J］. Eur J Pharm Biopharm，2015，94：170- 12（9）：877
179 ［41］DONG J，GAO H L，OUYANG D F. PharmSD：a novel
［29］LUO M，FENG Y Z，WANG T W，et al. Micro/nanorobots AI ⁃ based computational platform for solid dispersion
at work in active drug delivery［J］. Adv Funct Mater， formulation design［J］. Int J Pharm，2021，604：120705
2018，28（25）：1706100 ［42］ SUHAIL M，KHAN A，RAHIM M A，et al. Micro and
［30］NARAYANAN R R，DURGA N，NAGALAKSHMI S. Im⁃ nanorobot ⁃ based drug delivery：an overview［J］. J Drug
pact of artificial intelligence（AI）on drug discovery and Target，2022，30（4）：349-358
product development［J］. Ind J Pharm Edu Res，2022，56 ［43］YACOUB A S，AMMAR H O，IBRAHIM M，et al. Artifi⁃
（3S）：S387-S397 cial intelligence⁃assisted development of in situ forming
［31］ HORTELAO A C，SIM C，GUIX M，et al. Swarming nanoparticles for arthritis therapy via intra⁃articular deli⁃
behavior and in vivo monitoring of enzymatic nanomotors very［J］. Drug Deliv，2022，29（1）：1423-1436
within the bladder［J］. Sci Robot，2021，6（52）：eabd2823 ［44］ GELMAN R，HURVITZ N，NESSERAT R，et al. A second⁃
［32］VIDHYA K S，SULTANA A，NAVEEN KUMAR M，et al. generation artificial intelligence ⁃ based therapeutic regi⁃
Artificial intelligence’s impact on drug discovery and men improves diuretic resistance in heart failure：results
development from bench to bedside［J］. Cureus，2023，15 of a feasibility open ⁃ labeled clinical trial［J］. Biomed
（10）：e47486 Pharmacother，2023，161：114334
［33］ GHOLAP A D，UDDIN M J，FAIYAZUDDIN M，et al. ［45］HOUY N，LE GRAND F. Personalized oncology with arti⁃
Advances in artificial intelligence for drug delivery and ficial intelligence：the case of temozolomide［J］. Artif
development：a comprehensive review［J］. Comput Biol Intell Med，2019，99：101693
Med，2024，178：108702 ［46］ GROF Z，ŠTĚPANEK F. Artificial intelligence based
［34］NOORAIN，SRIVASTAVA V，PARVEEN B，et al. Artifi⁃ design of 3D ⁃ printed tablets for personalised medi⁃
cial intelligence in drug formulation and development： cine［J］. Comput Chem Eng，2021，154：107492
applications and future prospects［J］. Curr Drug Metab， ［47］AL⁃WDAN O A，SHARALLAH O A，ABDELWAHAB N
2023，24（9）：622-634 A，et al. Insights into microfabrication and implementa⁃
［35］ VORA L K，GHOLAP A D，JETHA K，et al. Artificial tion of microfluidics in pharmaceutical drug delivery and
intelligence in pharmaceutical technology and drug deli ⁃ analysis［J］. OpenNano，2023，12：100156
very design［J］. Pharmaceutics，2023，15（7）：1916 ［48］ YONET⁃TANYERI N，AMER M，BALMERT S C，et al.
［36］KHAN M Z，YOUSUF R I，SHOAIB M H，et al. A hybrid Microfluidic systems for manufacturing of microparticle⁃
framework of artificial intelligence⁃based neural network based drug ⁃ delivery systems：design，construction，and
model（ANN）and central composite design（CCD）in quali⁃ operation［J］. ACS Biomater Sci Eng，2022，8（7）：2864-
ty by design formulation development of orodispersible 2877
moxifloxacin tablets：physicochemical evaluation，compac⁃ ［49］ BANNIGAN P，ALDEGHI M，BAO Z Q，et al. Machine
tion analysis，and its in⁃silico PBPK modeling［J］. J Drug learning directed drug formulation development［J］. Adv
Deliv Sci Technol，2023，82：104323 Drug Deliv Rev，2021，175：113806
［37］ NOSRATI H ，NOSRATI M. Artificial intelligence in ［50］BLANCO⁃GONZALEZ A，CABEZON A，SECO⁃GONZA⁃
regenerative medicine：applications and implications［J］. LEZ A，et al. The role of AI in drug discovery：challenges，
Biomimetics，2023，8（5）：442 opportunities，and strategies［J］. Pharmaceuticals，2023，
［38］YADAV S，SINGH A，SINGHAL R，et al. Revolutionizing 16（6）：891
drug discovery：the impact of artificial intelligence on ［51］ NORORI N，HU Q Y，AELLEN F M，et al. Addressing
advancements in pharmacology and the pharmaceutical bias in big data and AI for health care：a call for open
industry［J］. Intell Pharm，2024，2（3）：367-380 （下转第934页）